Julie M. Skinner

Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model

Julie M. Skinner, Lani Indrawati, Jayme Cannon et al. · Vaccine · 2011 · 83 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial

Heather Platt, Tosin Omole, José F. Cardona et al. · The Lancet Infectious Diseases · 2022 · 82 citations

Veterinary Medicine, Immunology, Infectious Diseases +15

Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains

Susan Secore, Su Wang, Julie Doughtry et al. · PLoS ONE · 2017 · 37 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Comparison of rhesus and cynomolgus macaques in a Streptococcus pyogenes infection model for vaccine evaluation

Julie M. Skinner, Ivette Caro-Aguilar, Angela Payne et al. · Microbial Pathogenesis · 2010 · 29 citations

Veterinary Medicine, Infectious Diseases, Microbiology +16

Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197

Ivette Caro-Aguilar, Elizabeth A. Ottinger, Robert W. Hepler et al. · Human Vaccines & Immunotherapeutics · 2013 · 26 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17